ASMB
ASMB
NASDAQ · Biotechnology

Assembly Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$28.58
+0.12 (+0.42%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -61.8% upside
Low Target $9.01
Average Target $10.92
High Target $17.95
Current Price $28.58
Current
$28.58
Target
$10.92
$9.01 $10.92 avg $17.95
Scenario Analysis
Bear Case
$9.01
-68.5%
Low target
Base Case
$10.92
-61.8%
Avg target
Bull Case
$17.95
+-37.2%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$39.71
-28.0% from high
52-Week Low
$7.75
+268.8% from low
Target vs 52W High
$10.92
-72.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%